Impact of tofacitinib on patient-reported outcomes in patients with psoriatic arthritis. Data from the real clinical practice

L. D. Vorobyeva; T. V. Korotaeva; E. Yu. Loginova; Yu. L. Korsakova; E. E. Gubar; E. L. Nasonov

Rheumatology Science and Practice
Naučno-praktičeskaâ revmatologiâ

ISSN 1995-4484 (Print)
ISSN 1995-4492 (Online)

User

eng | рус

Rheumatology Science and Practice

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

Vorobyeva L.D., Korotaeva T.V., Loginova E.Yu., Korsakova Yu.L., Gubar E.E., Nasonov E.L. Impact of tofacitinib on patient-reported outcomes in patients with psoriatic arthritis. Data from the real clinical practice. Rheumatology Science and Practice. 2022;60(3):334-340. (In Russ.) https://doi.org/10.47360/1995-4484-2022-334-340

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1995-4484 (Print)
ISSN 1995-4492 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Rheumatology Science and Practice

For citations:

Cookies policy